73
Views
69
CrossRef citations to date
0
Altmetric
Article

Protein Tyrosine Kinase 6 Negatively Regulates Growth and Promotes Enterocyte Differentiation in the Small Intestine

, , , , , & show all
Pages 4949-4957 | Received 28 Sep 2005, Accepted 08 Apr 2006, Published online: 27 Mar 2023

REFERENCES

  • Accili, D., and K. C. Arden. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421–426.
  • Agellon, L. B., M. J. Toth, and A. B. Thomson. 2002. Intracellular lipid binding proteins of the small intestine. Mol. Cell Biochem. 239:79–82.
  • Barker, K. T., L. E. Jackson, and M. R. Crompton. 1997. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 15:799–805.
  • Biggs, W. H., III, J. Meisenhelder, T. Hunter, W. K. Cavenee, and K. C. Arden. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 96:7421–7426.
  • Born, M., L. Quintanilla-Fend, H. Braselmann, U. Reich, M. Richter, P. Hutzler, and M. Aubele. 2005. Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J. Pathol. 205:592–596.
  • Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868.
  • Cance, W. G., R. J. Craven, M. Bergman, L. Xu, K. Aitalo, and E. T. Liu. 1994. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells. Cell Growth Diff. 5:1347–1355.
  • Chen, H. Y., C. H. Shen, Y. T. Tsai, F. C. Lin, Y. P. Huang, and R. H. Chen. 2004. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol. Cell. Biol. 24:10558–10572.
  • Craven, R. J., W. G. Cance, and E. T. Liu. 1995. The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb. Cancer Res. 55:3969–3972.
  • Derry, J. J., G. S. Prins, V. Ray, and A. L. Tyner. 2003. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 22:4212–4220.
  • Derry, J. J., S. Richard, H. Valderrama Carvajal, X. Ye, V. Vasioukhin, A. W. Cochrane, T. Chen, and A. L. Tyner. 2000. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol. Cell. Biol. 20:6114–6126.
  • Fukumoto, S., C. M. Hsieh, K. Maemura, M. D. Layne, S. F. Yet, K. H. Lee, T. Matsui, A. Rosenzweig, W. G. Taylor, J. S. Rubin, M. A. Perrella, and M. E. Lee. 2001. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 276:17479–17483.
  • Gartel, A. L., M. S. Serfas, M. Gartel, E. Goufman, G. S. Wu, W. S. El-Deiry, and A. L. Tyner. 1996. p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelial and during differentiation of the Caco-2 intestinal cell line. Exp. Cell Res. 227:171–181.
  • Gregorieff, A., and H. Clevers. 2005. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 19:877–890.
  • Haegebarth, A., D. Heap, W. Bie, J. J. Derry, S. Richard, and A. L. Tyner. 2004. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. J. Biol. Chem. 279:54398–54404.
  • Haegebarth, A., R. Nunez, and A. L. Tyner. 2005. The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis. Cell Cycle 4:1239–1246.
  • Harvey, A. J., and M. R. Crompton. 2004. The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges. Anticancer Drugs 15:107–111.
  • Harvey, A. J., and M. R. Crompton. 2003. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 22:5006–5010.
  • Hay, N. 2005. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8:179–183.
  • He, X. C., J. Zhang, W. G. Tong, O. Tawfik, J. Ross, D. H. Scoville, Q. Tian, X. Zeng, X. He, L. M. Wiedemann, Y. Mishina, and L. Li. 2004. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36:1117–1121.
  • Kamalati, T., H. E. Jolin, M. J. Fry, and M. R. Crompton. 2000. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 19:5471–5476.
  • Kamalati, T., H. E. Jolin, P. J. Mitchell, K. T. Barker, L. E. Jackson, C. J. Dean, M. J. Page, B. A. Gusterson, and M. R. Crompton. 1996. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J. Biol. Chem. 271:30956–30963.
  • Kandel, E. S., and N. Hay. 1999. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253:210–229.
  • Lee, S. T., K. M. Strunk, and R. A. Spritz. 1993. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene 8:3403–3410.
  • Liang, J., and J. M. Slingerland. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339–345.
  • Llor, X., M. S. Serfas, W. Bie, V. Vasioukhin, M. Polonskaia, J. Derry, C. M. Abbott, and A. L. Tyner. 1999. BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin. Cancer Res. 5:1767–1777.
  • Lu, X., and Y. Li. 1999. Drosophila Src42A is a negative regulator of RTK signaling. Dev. Biol. 208:233–243.
  • Manning, B. D., M. N. Logsdon, A. I. Lipovsky, D. Abbott, D. J. Kwiatkowski, and L. C. Cantley. 2005. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19:1773–1778.
  • Meyer, T., L. Xu, J. Chang, E. T. Liu, R. J. Craven, and W. G. Cance. 2003. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase. Int. J. Cancer 104:139–146.
  • Minoguchi, M., S. Minoguchi, D. Aki, A. Joo, T. Yamamoto, T. Yumioka, T. Matsuda, and A. Yoshimura. 2003. STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif. J. Biol. Chem. 278:11182–11189.
  • Mitchell, P. J., K. T. Barker, J. E. Martindale, T. Kamalati, P. N. Lowe, M. J. Page, B. A. Gusterson, and M. R. Crompton. 1994. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene 9:2383–2390.
  • Mitchell, P. J., E. A. Sara, and M. R. Crompton. 2000. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. Oncogene 19:4273–4282.
  • Persad, S., A. A. Troussard, T. R. McPhee, D. J. Mulholland, and S. Dedhar. 2001. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol. 153:1161–1174.
  • Petro, B. J., R. C. Tan, A. L. Tyner, M. W. Lingen, and K. Watanabe. 2004. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium. Oral Oncol. 40:1040–1047.
  • Radtke, F., and H. Clevers. 2005. Self-renewal and cancer of the gut: two sides of a coin. Science 307:1904–1909.
  • Rubin, D. C., D. E. Ong, and J. I. Gordon. 1989. Cellular differentiation in the emerging fetal rat small intestinal epithelium: mosaic patterns of gene expression. Proc. Natl. Acad. Sci. USA 86:1278–1282.
  • Rubin, D. C., E. A. Swietlicki, J. L. Wang, B. D. Dodson, and M. S. Levin. 1996. Enterocytic gene expression in intestinal adaptation: evidence for a specific cellular response. Am. J. Physiol. 270:G143–G152.
  • Schwarz, M., E. G. Lund, K. D. Setchell, H. J. Kayden, J. E. Zerwekh, I. Bjorkhem, J. Herz, and D. W. Russell. 1996. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J. Biol. Chem. 271:18024–18031.
  • Serfas, M. S., and A. L. Tyner. 2003. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol. Res. 13:409–419.
  • Siyanova, E. Y., M. S. Serfas, I. A. Mazo, and A. L. Tyner. 1994. Tyrosine kinase gene expression in the mouse small intestine. Oncogene 9:2053–2057.
  • Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70–71.
  • Tappenden, K. A. 2006. Mechanisms of enteral nutrient-enhanced intestinal adaptation. Gastroenterology 130:S93–S99.
  • Tian, Q., M. C. Feetham, W. A. Tao, X. C. He, L. Li, R. Aebersold, and L. Hood. 2004. Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc. Natl. Acad. Sci. USA 101:15370–15375.
  • Tran, H., A. Brunet, E. C. Griffith, and M. E. Greenberg. 2003. The many forks in FOXO's road. Sci. STKE 2003:RE5.
  • Vasioukhin, V., M. S. Serfas, E. Y. Siyanova, M. Polonskaia, V. J. Costigan, B. Liu, A. Thomason, and A. L. Tyner. 1995. A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract. Oncogene 10:349–357.
  • Vasioukhin, V., and A. L. Tyner. 1997. A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation. Proc. Natl. Acad. Sci. USA 94:14477–14482.
  • Vassileva, G., L. Huwyler, K. Poirier, L. B. Agellon, and M. J. Toth. 2000. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J. 14:2040–2046.
  • Wang, T. C., S. H. Jee, T. F. Tsai, Y. L. Huang, W. L. Tsai, and R. H. Chen. 2005. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells. Br. J. Dermatol. 153:282–289.
  • Wang, Y., H. Iordanov, E. A. Swietlicki, L. Wang, C. Fritsch, T. Coleman, C. F. Semenkovich, M. S. Levin, and D. C. Rubin. 2005. Targeted intestinal overexpression of the immediate early gene tis7 in transgenic mice increases triglyceride absorption and adiposity. J. Biol. Chem. 280:34764–34775.
  • Zhang, P., J. H. Ostrander, E. J. Faivre, A. Olsen, D. Fitzsimmons, and C. A. Lange. 2005. Regulated association of protein kinase B/Akt with breast tumor kinase. J. Biol. Chem. 280:1982–1991.
  • Zhang, Q., Q. Zheng, and X. Lu. 1999. A genetic screen for modifiers of Drosophila Src42A identifies mutations in Egfr, rolled and a novel signaling gene. Genetics 151:697–711.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.